SEQENS to launch bio-identical hexapeptide-9 for sustainable anti-aging formulations
Last update on Apr 7, 2026
SEQENS offers sustainable and advanced cosmetic solutions to shape the future of personal care with its customers and partners.
The group is set to launch PeptiCode™ HP-9, claimed by the company to be one of the first European biotech Hexapeptide-9, developed through the PeptiCode™ biotechnology platform based in Nîmes, France. This platform specializes in various microorganisms’ optimization - such as bacteria, yeast, and microalgae - through strain engineering and fermentation technologies to unlock access to sustainable and innovative naturally derived peptides.
Interested in SEQENS' ingredients? Explore their profile now!
Harnessing the power of optimized microorganism
PeptiCode™ HP-9 is created via precision fermentation, harnessing the power of an optimized microorganism to synthesize a pure, 100% natural origin and bio-identical hexapeptide-9. SEQENS’ process complies with the principles of Green Engineering and ensures high performance and optimal peptide stability without using TFA (trifluoroacetic acid) or PFAS (per- and polyfluoroalkyl substances) during production.
This versatile product is designed for new sustainable anti-aging formulations, as it acts as a signal peptide to boost collagen synthesis. Easy to use and interchangeable with its synthetic counterpart, PeptiCode™ HP-9 is a drop-in replacement. It offers the advantage of avoiding chemical synthesis, while guaranteeing a high-performance, environmentally friendly product.
Anti-aging agents: How to select the right grade for cosmetics?>> See here >>
SEQENS will exhibit at in-cosmetics Global 2026 in Paris. Visit them at stand #3Q48 to discover PeptiCode™ HP-9 and the PeptiCode™ platform, designed to develop innovative peptides that contribute to a more sustainable, biotechnology-focused future, meeting the needs of next-generation beauty and personal care products.